Novelty Nobility, Inc.
Novelty Nobility is a biotech company focused on antibody design and discovery, overcoming drug resistance with antibody-drug conjugates, and bringing innovative solutions to healthcare. They are engaged in antibody research, clinical trials, and technological development to advance medical treatments.
Industries
Nr. of Employees
small (1-50)
Novelty Nobility, Inc.
Seongnam, Kyonggi-do, South Korea, Asia
Patents
Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
US-9528112-B2
View Details
Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
US-9528112-B2
View DetailsProducts
Fit-for-purpose antibody design & discovery platform
A platform for designing and discovering therapeutic antibodies, supporting generation of candidate leads and optimization for intended applications.
Antibody-drug conjugate oncology candidates (pipeline)
Antibody-drug conjugate programs targeting cancer indications, with development emphasis on overcoming resistance mechanisms.
Ophthalmic biologics program
Programs focused on developing biologic approaches intended to improve ocular outcomes or aspects of vision.
Fit-for-purpose antibody design & discovery platform
A platform for designing and discovering therapeutic antibodies, supporting generation of candidate leads and optimization for intended applications.
Antibody-drug conjugate oncology candidates (pipeline)
Antibody-drug conjugate programs targeting cancer indications, with development emphasis on overcoming resistance mechanisms.
Ophthalmic biologics program
Programs focused on developing biologic approaches intended to improve ocular outcomes or aspects of vision.
Services
Provision of platform-driven antibody discovery and optimization services for therapeutic lead generation and fit-for-purpose design.
Development and translational support for ADC programs, including design strategies aimed at mitigating drug resistance.
Provision of platform-driven antibody discovery and optimization services for therapeutic lead generation and fit-for-purpose design.
Development and translational support for ADC programs, including design strategies aimed at mitigating drug resistance.
Expertise Areas
- Antibody engineering
- Antibody-drug conjugate development
- Oncology drug development and clinical translation
- Ophthalmic biologics development
Key Technologies
- Antibody engineering
- Antibody-drug conjugates (ADC)
- Biologic discovery platforms
- Ophthalmic biologics
News & Updates
Medico Pharma reports that Novelty Nobility is advancing clinical trials for ADC anticancer drugs in the US.
The company has voluntarily withdrawn its preliminary review for KOSDAQ listing.
Selected by Johnson & Johnson to participate in JLABS Korea.
The company emphasizes ADC as its core competency and discusses strategic technology transfer.
The company has filed for preliminary review and is making efforts to pursue new licensing opportunities.
Medico Pharma reports that Novelty Nobility is advancing clinical trials for ADC anticancer drugs in the US.
The company has voluntarily withdrawn its preliminary review for KOSDAQ listing.
Selected by Johnson & Johnson to participate in JLABS Korea.
The company emphasizes ADC as its core competency and discusses strategic technology transfer.
The company has filed for preliminary review and is making efforts to pursue new licensing opportunities.